Company Filing History:
6 out of 1,189 
2 out of 2,081 
Years Active: 2002-2009
Title: Clare H McGowan: Innovator in Cell Cycle Checkpoint Genes
Introduction
Clare H McGowan is a prominent inventor based in Del Mar, CA (US). She has made significant contributions to the field of molecular biology, particularly in the area of cell cycle checkpoint genes and DNA repair mechanisms. With a total of 6 patents to her name, her work has had a profound impact on scientific research and potential therapeutic applications.
Latest Patents
Among her latest patents, one notable invention is related to human and murine Mus81 proteins. This invention encompasses novel mammalian cell cycle checkpoint genes and DNA repair genes, including cDNA or genomic DNA, isolated nucleic acids, and proteins encoded by these genes. Additionally, it includes expression vectors comprising said nucleic acids, host cells transformed with these vectors, and methods for treating a cell using such nucleic acids or proteins. Another significant patent involves a novel human checkpoint kinase gene, hCDS1. This invention comprises the nucleic acid sequence of residues 66-1694 of SEQ ID NO: 1, along with a protein expressed from the gene, fragments, and functional equivalents of the protein. It also provides for pharmaceutical compositions comprising a hCDS1 protein and methods utilizing the protein.
Career Highlights
Clare has worked with esteemed organizations such as The Scripps Research Institute and Janssen Pharmaceutica NV. Her work in these institutions has allowed her to advance her research and contribute to groundbreaking discoveries in her field.
Collaborations
Throughout her career, Clare has collaborated with notable colleagues, including Walter H M L Luyten and Andrew E Parker. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Clare H McGowan is a distinguished inventor whose work in cell cycle checkpoint genes and DNA repair has paved the way for advancements in molecular biology. Her contributions continue to influence research and potential therapeutic strategies in the scientific community.